Polyomavirus BK

Lancet Infectious Diseases

Volumn 3, Issue 10, 2003, Pages 611-623

  Hirsch, Hans H ^a   Steiger, Jürg ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR;

BK VIRUS; CANCER; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; ENCEPHALITIS; HEMORRHAGIC CYSTITIS; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PNEUMONIA; POPULATION; PREVALENCE; PRIORITY JOURNAL; RETINITIS; REVIEW; URETER OBSTRUCTION; URINE CYTOLOGY; VASCULAR DISEASE; VIRAL GENETICS; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS LOAD;

EID: 0141534253     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00770-9     Document Type: Review

References (156)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (BK) isolated from urine after transplantation. Lancet 1971; 1: 1253-57.
2. Padgett BL, Walker DL, Zu Rhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-60.
3. Fernandez-Cobo M, Agostini HT, Britez G, Ryschkewitsch CF, Stoner GL. Strains of JC virus in Amerind-speakers of North America (Salish) and South America (Guarani), Na-Dene-speakers of New Mexico (Navajo), and modern Japanese suggest links through an ancestral Asian population. Am J Phys Anthropol 2002; 118: 154-68.
4. Stoner GL, Hübner R. The human polyomaviruses: past, present and future. In: Khalili K, Stoner GL, eds Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss; 2003: 611-63.
5. Hirsch HH. Polyomavirus BK nephropathy: a (re-) emerging complication in renal transplantation. Am J Transplant 2002; 2: 25-30.
6. Fishman JA. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med 2002; 347: 527-30.
7. Drachenberg CB, Papadimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: Ultrastructural features from viral cell entry to lysis. Am J Transplant (in press).
8. Binet I, Nickeleit V, Hirsch HH, et al. Polyomovirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-22.
9. Randhawa PS, Vats A, Zygmunt D, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74: 485-88.
10. Rubinstein R, Pare N, Harley EH. Structure and function of the transcriptional control region of nonpassaged BK virus. J Virol 1987; 61: 1747-50.
11. Moens U, Rekvig OP. Molecular biology of BK virus and clinical and basic aspectes of BK virus renal infection. In: Khalili K, Stoner GL, eds. Human polyomaviruses; molecular and clinical perspectives. New York: Wiley-Liss; 2001: 215-26.
12. Jin L, Gibson PE, Booth JC, Clewley JP. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 1993; 41: 11-17.
13. Jin L, Gibson PE, Knowles WA, Clewley JP. BK virus antigenic variants: sequence analysis within the capsid VP1 epitope. J Med Virol 1993; 39: 50-56.
14. Shah KV, Daniel R, Warszawski R. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973;128:784-87.
15. Knowles WA. The epidemiology of BK Virus and the occurrence of antigenic and genomic subtypes. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss; 2001: 527-59.
16. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147: 676-84.
17. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53: 263-76.
18. Sundsfjord A, Osei A, Rosenqvist H, et al. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180: 1-9.
19. Ling PD, Lednicky JA, Keitel WA, et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003; 187: 1571-80.
20. Dolei A, Pietropaolo V, Gomes E, et al. Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 2000; 81: 1967-73.
21. Dorries K. Latent and persistent polyomavirus infection. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss; 2001: 197-235.
22. Goudsmit I, Wertheim-van Dillen P, van Strien A, van der NJ. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10: 91-99.
23. Brown DW, Gardner SD, Gibson PE, Field AM. BK virus specific IgM responses in cord sera, young children and healthy adults detected by RIA. Arch Virol 1984; 82: 149-60.
24. Sundsfjord A, Spein AR, Lucht E, Flaegstad T, Seternes OM, Traavik T. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J Clin Microbiol 1994; 32: 1390-94.
25. Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000; 66: 238-45.
26. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F, Girones R. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to Virions or viral DNA. J Virol 2001; 75: 10290-99.
27. Pietropaolo V, Di Taranto C, Degener AM, et al. Transplacental transmission of human polyomavirus BK. J Med Virol 1998; 56: 372-6.
28. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158: 176-81.
29. Shah KV. Human polyomavirus BKV and renal disease. Nephrol Dial Transplant 2000; 15; 754-55.
30. Corallini A, Barbanti-Brodano G, Portolani M, et al. Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia. Infect Immun 1976; 13: 1684-91.
31. Drummond JE, Shah KV, Donnenberg AD. Cell-mediated immune responses to BK virus in normal individuals. J Med Virol 1985; 17: 237-47.
32. Drummond JE, Shah KV, Saral R, Santos GW, Donnenberg AD. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients. J Med Virol 1987; 23: 331-44.
33. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 1980; 74: 326-32.
34. Hogan TF, Padgett BL, Walker DL, Borden EC, Frias Z. Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma. Prog Clin Biol Res 1983; 105: 311-24.
35. Sundsfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169: 485-90.
36. Gardner SD, Mackenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578-86.
37. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167: 13-20.
38. Knowles WA, Pillay D, Johnson MA, Hand JF, Brown DW. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999; 59: 474-79.
39. Koralnik IJ, Du Pasquier RA, Kuroda MI, et al. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002; 168: 499-504.
40. Richardson EP Jr, Johnson PC. Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol Suppl (Berl) 1975; suppl 6: 247-50: 247-50.
41. Mazlo M, Ressetar HG, Stoner GL. The neuropathology and pathogenesis of progressive multifocal leukoencephalopathy. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss; 2001: 257-335.
42. Rosen S, Harmon W, Krensky AM, et al. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 1983; 308: 1192-96.
43. de Silva LM, Bale P, de Courcy J, Brown D, Knowles W. Renal failure due to BK virus infection in an immunodeficient child. J Med Virol 1995; 45: 192-96.
44. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-09.
45. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-89.
46. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001; 1: 373-81.
47. van Gorder MA, Della PP, Henson JW, Sachs DH, Cosimi AB, Colvin RB. Cynomolgus polyomavirus infection: a new member of the polyomavirus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys. Am J Pathol 1999; 154: 1273-84.
48. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72: 1587-92.
49. Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35: 1250-57.
50. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447-54.
51. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-09.
52. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant 2000; 5: 210-16.
53. Corallini A, Tognon M, Negrini M, Barbanti-Brodano G. Evidence for BK virus as a human tumor virus. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molceular and clinical perspectives. NewYork; Wiley-Liss; 2001; 431-60.
54. Hirsch HH, Steiger J, Mihatsch MJ. Immunosuppression and BKV nephropathy. N Engl J Med 2002; 347: 2079-80.
55. Possati L, Bartolotta E. Attempts to isolate BK virus from children affected by various diseases. Acta Virol 1981; 25: 254-55.
56. Saitoh K, Sugae N, Koike N, Akiyama Y, Iwamura Y, Kimura H. Diagnosis of childhood BK virus cystitis by electron microscopy and PCR. J Clin Pathol 1993; 46: 773-75.
57. Hashida Y, Gaffney PC, Yunis EJ. Acute hemorrhagic cystitis of childhood and papovavirus-like particles. J Pediatr 1976; 89: 85-87.
58. Nagao S, Iijima S, Suzuki H, Yokota T, Shigeta S. BK virus-like particles in the urine of a patient with nephrotic syndrome-an electron microscopic observation. Fukushima J Med Sci 1982; 29: 45-49.
59. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM. BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch Dis Child 2003; 88: 174-75.
60. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000; 343: 1313-24.
61. Sundfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169: 485-90.
62. Filie AC, Wilder AM, Brosky K, Kopp JB, Miller KD, Abati A. Urinary cytology associated with human polyomavirus and indinavir therapy in HIV-infected patients. Am J Clin Pathol 2002; 117: 922-26.
63. Di Taranto C, Pietropaolo V, Orsi GB, Jin L, Sinibaldi L, Degener AM. Detection of BK polyomavirus genotypes in healthy and HIV-positive children. Eurl Epidemiol 1997; 13: 653-57.
64. Nebuloni M, Tosoni A, Boldorini R, et al. BK virus renal infection in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1999; 123: 807-11.
65. Smith RD, Galla JH, Skahan K, et al. Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease. J Clin Microbiol 1998; 36: 1660-65.
66. Vallbracht A, Lohler J, Gossmann J, et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993; 143: 29-39.
67. Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13: 1071-75.
68. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphoma. AIDS 2001; 15: 1196-99.
69. Cubukcu-Dimopulo O, Greco A, Kumar A, Karluk D, Mittal K, Jagirdar J. BK virus infection in AIDS. Am J Surg Pathol 2000; 24: 145-49.
70. Boldorini R, Omodeo-Zorini E, Nebuloni M, et al. Lytic JC virus infection in the kidneys of AIDS subjects. Mod Pathol 2003; 16: 35-42.
71. Gluck TA, Knowles WA, Johnson MA, Brook MG, Pillay D. BK virus-associated haemorrhagic cystitis in an HIV-infected man. AIDS 1994; 8: 391-92.
72. Barouch DH, Faquin WC, Chen Y, Koralnik IJ, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis 2002; 33: 326-29.
73. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373-78.
74. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-96.
75. Coleman DV, Mackenzie EF, Gardner SD, Poulding JM, Amer B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol 1978; 31: 338-47.
76. Mackenzie EF, Poulding JM, Harrison PR, Amer B. Human polyoma virus (HPV)-a significant pathogen in renal transplantation. Proc Eur Dial Transplant Assoc 1978; 15: 352-60.
77. Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26: 671-3.
78. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. In: JM Cecka, PI Terasaki, eds. Clinical transplantation 2002. Los Angeles, CA, USA: UCLA Immunogenetics Center; 2003: 143-53.
79. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus allograft nephropathy. J Infect Dis 2001; 184: 1494-5.
80. Trofe J, Cavallo T, First M, et al. Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc 2002; 34: 1788.
81. Li RM, Mannon RB, Kleiner D, et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002: 74: 1497-504.
82. Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation 2001; 71: 1300-03.
83. Boldorini R, Omodeo-Zorini E, Suno A, et al. Molecular characterization and sequence analysis of polyomavirus strains isolated from needle biopsy specimens of kidney allograft recipients. Am J Clin Pathol 2001; 116: 489-94.
84. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190-96.
85. Mathur VS, Olson JL, Darragh TM, Yen TS. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis 1997; 29: 754-8.
86. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279-88.
87. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-15.
88. Hurault de Ligny B, Etienne I, Francois A, et al. Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc 2000; 32: 2760-61.
89. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896-99.
90. Barri YM, Ahmad I, Ketel BL, et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant 2001; 15: 240-46.
91. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-51.
92. Trofe J, Gaber LW, Stratta RJ, et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003; 5: 21-28.
93. Smith JM, McDonald RA, Limaye AP. BK polyoma virus nephropathy in pediatric renal transplant patients: A case series. J Am Soc Nephrol 2002; 13: 780A.
94. Kang YN, Han SM, Park KK, Jeon DS, Kim HC. BK virus infection in renal allograft recipients. Transplant Proc 2003; 35: 275-77.
95. Rahaminov R, Lustig S,Tovar A, et al. BK polyoma virus nephropathy in kidney transplant recipients: the role of new immunosuppressive agents. Transplant Proc 2003; 35: 604-5.
96. Maiza H, Fontaniere B, Dijoud F, Pouteil-Noble C. Graft dysfunction and polyomavirus infection in renal allograft recipients. Transplant Proc 2002; 34: 809-11.
97. Buehrig CK, Lager DI, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665-73.
98. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266-70.
99. Lu W, Blauhut S, Bartlett ST, et al. Risk factors for BK virus infection in renal transplant patients. Am J Transplant 2001; 1: 292.
100. Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 424-32.
101. Moens U, Subramaniam N, Johansen B, Johansen T, Traavik T. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol 1994; 68: 2398-408.
102. Trofe J, Roy-Chaudhury P, Gordon J, et al. Early steroid cessation/avoidance regimens are associated with a lower incidence of polyomavirus nephropathy. Am J Transplant 2003; 3: 371.
103. Baksh FK, Finkelstein SD, Swalsky PA, Stoner GL, Ryschkewitsch CF, Randhawa P. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 2001; 38: 354-65.
104. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA, et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002; 73: 1090-94.
105. Randhawa PS, Zygmunt D, Shapiro R, et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int 2003; 64: 743-47.
106. Nickdeit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, Mhaemorrhagic cystitis-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324-32.
107. Roy-Chaudhury P, Mutema G, Trofe J, et al. Interstitial infiltrates in polyomavirus nephropathy: Cellular phenotyping and correlation with clinical parameters. Am J Transplant 2003; 3 (suppl 5): 189.
108. Colvin RB, Mauiyyedi S. Differential diagnosis between infection and rejection in renal allografts. Transplant Proc 2001; 33: 1778-79.
109. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MI. Detection of the complement degradation product c4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242-51.
110. Vats A, Shapiro R, Singh RP, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105-12.
111. Ding R, Medeiros M, Dadhania D, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 2002; 74: 987-94.
112. Drachenberg CB, Hirsch HH, Papadimitriou JC, Wali R, Bourquin PM, Ramos E. Quantitative measurements of BK viral load in plasma correlates with urine cytology and presence of BK nephropathy. Am J Transplant 2003; 5: 371.
113. Hirsch HH. VP1 messenger RNA levels in urine for diagnosing BK virus nephropathy? Transplantation 2003; 75: 2160.
114. Limaye AP, Jerome KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183: 1669-72.
115. Agha I, Alvaraz A, Lopez-Rocafort L, et al. A prospective evaluation of BK virus infection in renal transplant patients. Am J Transplant 2002; 2: 260.
116. Ramos E, Drachenberg CB, Portocarrero M, et al. Effects of type of immunosuppression reduction in patients with BK allograft nephropathy. Am J Transplant 2003; 3: 561.
117. Wali R, Drachenberg CB, Hirsch HH, et al. Early detection of BK virus-associated nephropathy in renal allograft recipients and modification of immunosuppressive therapy to combinations with sirolimus and prednisone is associated with a reduction in BK viremia and improvement of allograft function. Am J Transplant 2003; 3: 371.
118. Poduval RD, Kadambi PV, Javaid B, et al. Leflunomide: a potential new therapeutic agent for BK nephropathy. Am J Transplantation 2003; 3: 189.
119. Mayr M, Nickeleit V, Hirsch HH, Dickenmann M, Mihatsch MJ, Steiger J. Polyomavirus BK nephropathy in a kidney transplant recipient: critical issues of diagnosis and management. Am J Kidney Dis 2001; 38: 13E.
120. Hussain S, Bresnahan BA, Cohen EP, Hariharan S. Rapid kidney allograft failure in patients with polyomavirus nephritis with prior treatment with antilymphocyte agents. Clin Transplant 2002; 16: 43-47.
121. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587-93.
122. Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter I. J Am Soc Nephrol 2000; 11: 383-93.
123. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3: 186-91.
124. Poduval RD, Meehan SM, Woodle ES, et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 2002; 73: 1166-69.
125. Ramos E, Drachenberg CB, Lu W, et al. Retransplant in patients whose first renal allograft was lost to BK-associated nephropathy. Am J Transplant 2003; 3: 189.
126. Boucek P, Voska L, Saudek F. Successful retransplantation after renal allograft loss to polyoma virus interstirial nephritis. Transplantation 2002; 74: 1478.
127. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345: 1250-55.
128. Traavik T, Uhlin-Hansen L, Flaegstad T, Christie KE. Antibody-mediated enhancement of BK virus infection in human monocytes and a human macrophage-like cell line. J Med Virol 1988; 24: 283-97.
129. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a casual transforming agent. Transplantation 2002; 73: 1933-36.
130. Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2000; 73: 1350-53.
131. Etienne I, Francois A, Redonnet M, et al. Does polyomavirus infect [on induce renal failure in cardiac transplant recipients? Transplant Proc 2000; 32: 2794-95.
132. Puliyanda D, Amet N, Dhawan A, et al. Heart and liver transplant recipients are at a low risk for BK viremia and nephropathy. Am J Transplant 2003; 3: 510 (abstr 1397).
133. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT): incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood 1993; 91: 1469-77.
134. Peinemann F, de Villiers EM, Dorries K, Adams O, Vogeli TA, Burdach S. Clinical course and treatment of haemorrhagic cytitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr 2000; 159: 182-8.
135. Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35-40.
136. Kondo M, Kojima S, Kato K, Matsuyama T. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Borie Marrow Transplant 1998; 22: 995-98.
137. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230-34.
138. Cotterill HA, Macaulay ME, Wong V. Reactivation of polyomavirus in bone marrow transplant recipients. J Clin Pathol 1992; 45: 445.
139. Bogdanovic G, Ljungman P, Wang F, Dalianis T. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis. Bone Marrow Transplant 1996; 17: 573-36.
140. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971-78.
141. Childs R, Sanchez C, Engler H, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998; 22: 889-93.
142. Vats A, Shapiro R, Randhawa PS, et al. BK virus associated nephropathy and cidofovir: long term experience. Am J Transplant 2003; 3: 190.
143. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325-30.
144. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871-76.
145. Azzi A, Cesaro S, Laszlo D, et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14: 79-86.
146. Priftakis P, Bogdanovic G, Kokhaei P, Mellstedt H, Dalianis T. BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist. J Clin Virol 2003; 26: 71-77.
147. Priftakis P, Bogdanovic G, Kalantari M, Dalianis T. Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis. J Clin Virol 2001; 21: 1-7.
148. Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158: 563-69.
149. Bogdanovic G, Priftakis P, Taemmeraes B, et al. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children. Pediatr Transplant 1998; 2: 288-93.
150. Kawakami M, Ueda S, Maeda T, et al. Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 485-90.
151. Held TK, Biel SS, Nitsche A, et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous cytomegalovirus reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347-50.
152. O'Reilly RJ, Lee FK, Grossbard E, et al. Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction. Transplant Proc 1981; 13: 262-66.
153. Iwamoto S, Azuma E, Hori H, et al. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatr Hematol Oncol 2002; 19: 255-61.
154. Sandler ES, Aquino VM, Goss-Shohet E, Hinrichs S, Krisher K. BK papova virus pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997; 20: 163-65.
155. Barthel MF, Becker C, McCarthy ET. Interstitial nephritis due to polyomavirus in untreated systemic lupus erythematosus. J Am Soc Nephrol 2002; 13: 690A (abstr 098).
156. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-23.